To further investigate the impact of DMPK CTGexp mutation on the ASD-risk gene splicing program in the developing human brain, we also analyzed DM1 and control brain organoid RNA-seq samples52 followed by the differential splicing and ASD-risk gene enrichment analyses. The gene discussed is DMPK; the disease is myotonic dystrophy type 1.